Grand Rounds, September 10, 2026


August 26, 2026

Presentation Title: Systemic sclerosis in its early stages: an evidence-based approach to assessment, diagnosis, and personalized management
Speaker: Brian Skaug, MD, PhD

Date: Thursday, September 10, 2026
Time: 12:00 PM – 1:00 PM
Location: MSB 2.103
Learning Format: In-Person and Online

Series Objectives:

  • Apply the latest evidence with patients and practice evidence-based medicine.
  • Discuss current research and its potential for application to patient care.
  • Discuss the latest clinical practice guidelines relevant to clinical practice.

Activity Objectives:
At the conclusion of this activity, participants should be able to:

  • Identify clinical presentations that should prompt an evaluation for systemic sclerosis
  • Utilize a concise physical exam and ANA testing approach that can lead to an early diagnosis
  • Apply currently available clinical and serologic prognostic tools for personalized management

Credit Designation:

  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Event Disclosures:

Speakers:

Brian Skaug, MD, PhD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Planners and other Administrative Support:
Karla Abela, PhD, RN, CCRN, CPN, Aastha V Bharwad, MD, Latese McCowan, MA, Andrew Sullivan, MD, Carley Allen, MD, Philip Orlander, MD, Gabriel Aisenberg, MD, Jeffrey Chen, MD, Mark A Farnie, MD, Robby Wesley, DO, FACP, Jillian Smith, MD, and Cristina M Natha, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Commercial Support:
This activity is not commercially supported.

Accreditation Statement:

  • McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Related topics